Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)

NARecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Nonvalvular Atrial FibrillationSevere Degenerative Mitral Regurgitation
Interventions
PROCEDURE

MitraClip TMVR and Watchman LAAO

The MitraClip device is a percutaneous edge-to-edge repair device that is intended to approximate the anterior and posterior mitral valve leaflets in patients with severe symptomatic mitral regurgitation with suitable anatomy. Device versions/types: MitraClip NTr, MitraClip XTr. The WATCHMAN device is a self-expanding left atrial appendage occlusion (LAAO) device with a porous covering on the proximal face. Device sizes: 21 mm, 24 mm, 27 mm, 30 mm, 33 mm.

Trial Locations (2)

55905

RECRUITING

Mayo Clinic, Rochester

K1Y 4W7

ACTIVE_NOT_RECRUITING

Ottawa Heart Institute, Ottawa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04494347 - Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR) | Biotech Hunter | Biotech Hunter